cholestyramine vs methylprednisolone
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of cholestyramine and methylprednisolone. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Cholestyramine: Cholestyramine may increase the clearance of oral corticosteroids.
Questran
Medrol
Cholestyramine is a medicine that helps lower high cholesterol levels in your blood. It works by preventing your body from absorbing cholesterol in the intestines.
Methylprednisolone (Medrol) is a corticosteroid medicine. It reduces inflammation and affects the immune system.
This medicine is used with a diet to lower high cholesterol, especially LDL cholesterol (the "bad" cholesterol). It may also help if you have high triglycerides, but it's not the best choice if high triglycerides are your main problem. Lowering cholesterol helps reduce your risk of heart disease.
This medicine can treat many conditions. It can help with allergies, skin problems, and hormone imbalances. It can also help with gut and blood disorders.
Cholestyramine is a resin that binds to bile acids in your intestines. Bile acids help digest fats, including cholesterol. By binding to bile acids, cholestyramine prevents them from being reabsorbed, so your body uses cholesterol to make more bile acids, which lowers cholesterol levels in your blood.
Methylprednisolone reduces inflammation in the body. It also changes how your immune system works. This can help control symptoms of different diseases.
- • Constipation
No common side effects listed.
- Diarrhoea 1,631
- Fatigue 877
- Nausea 783
- Arthralgia 621
- Headache 543
- Fatigue 7,793
- Pain 7,274
- Nausea 7,213
- Headache 7,058
- Pyrexia 6,883
Since cholestyramine can affect how your body absorbs other medicines, take other drugs at least 1 hour before or 4 to 6 hours after taking cholestyramine.
This medicine is not for injection into the spine. This can cause serious medical problems. Do not take this medicine if you have a fungal infection, unless it's a localized joint condition.
Tell your doctor if you are pregnant or plan to become pregnant. Cholestyramine may affect how you absorb vitamins, so your doctor may recommend supplements. Talk to your doctor about the risks and benefits of taking this medicine while breastfeeding.
Tell your doctor if you are pregnant or plan to become pregnant. This medicine may harm your unborn baby. Talk to your doctor about the risks and benefits.
Also Compare, Nearby Drugs
Compare cholestyramine with
Compare methylprednisolone with
How to Read This cholestyramine vs methylprednisolone Comparison
cholestyramine is classified in the Bile Acid Sequestrant drug class, while methylprednisolone sits within the Corticosteroid class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, cholestyramine has 4,455 submissions while methylprednisolone has 36,221. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to cholestyramine makes your body get rid of the steroid medicine faster than it normally would.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for cholestyramine or methylprednisolone.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.